Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Orphanet Journal of Rare Diseases
Published in: Orphanet Journal of Rare Diseases 1/2022

Open Access 01-12-2022 | Fatigue | Review

Experienced fatigue in people with rare disorders: a scoping review on characteristics of existing research

Authors: Trine Bathen, Heidi Johansen, Hilde Strømme, Gry Velvin

Published in: Orphanet Journal of Rare Diseases | Issue 1/2022

Login to get access

Abstract

Background

Experienced fatigue is an under-recognized and under-researched feature in persons with many different rare diseases. A better overview of the characteristics of existing research on experienced fatigue in children and adults with rare diseases is needed. The purpose of this review was to map and describe characteristics of existing research on experienced fatigue in a selection of rare diseases in rare developmental defects or anomalies during embryogenesis and rare genetic diseases. Furthermore, to identify research gaps and point to research agendas.

Methods

We applied a scoping review methodology, and performed a systematic search in March 2020 in bibliographic databases. References were sorted and evaluated for inclusion using EndNote and Rayyan. Data were extracted on the main research questions concerning characteristics of research on experienced fatigue (definition and focus on fatigue, study populations, research questions investigated and methods used).

Results

This review included 215 articles on ten different rare developmental defects/anomalies during embryogenesis and 35 rare genetic diseases. Of the 215 articles, 82 had investigation of experienced fatigue as primary aim or outcome. Included were 9 secondary research articles (reviews) and 206 primary research articles. A minority of articles included children. There were large differences in the number of studies in different diseases. Only 29 of 215 articles gave a description of how they defined the concept of experienced fatigue. The most common research-question reported on was prevalence and/ -or associations to fatigue. The least common was diagnostics (development or validation of fatigue assessment methods for a specific patient group). A large variety of methods were used to investigate experienced fatigue, impeding comparisons both within and across diagnoses.

Conclusion

This scoping review on the characteristics of fatigue research in rare diseases found a large variety of research on experienced fatigue. However, the minority of studies had investigation of experienced fatigue as a primary aim. There was large variation in how experienced fatigue was defined and also in how it was measured, both within and across diagnoses. More research on experienced fatigue is needed, both in children and adults with rare diseases. This review offers a basis for further research.
Appendix
Available only for authorised users
Literature
1.
von der Lippe C, Diesen PS, Feragen KB. Living with a rare disorder: a systematic review of the qualitative literature. Mol Genet Genomic Med. 2017;5(6):758–73.PubMedPubMedCentralCrossRef
2.
Grut L, Kvam MH. Facing ignorance: people with rare disorders and their experiences with public health and welfare services. Scand J Disabil Res. 2013;15(1):20–32.CrossRef
3.
4.
Wakap SN, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165–73.CrossRef
5.
Boycott KM, Rath A, Chong JX, Hartley T, Alkuraya FS, Baynam G, et al. international cooperation to enable the diagnosis of all rare genetic diseases. Am J Hum Genet. 2017;100(5):695–705.PubMedPubMedCentralCrossRef
6.
7.
Friedberg F, Caikauskaite I, Adamowicz J, Bivona TJ, Njoku G. Scientific status of fatigue and pain. Publishing and professional activities: 2002–2011. Fatigue: Biomed Health Behav. 2013;1(1–2):4–11.
8.
9.
Zwarts MJ, Bleijenberg G, van Engelen BG. Clinical neurophysiology of fatigue. Clin Neurophysiol. 2008;119(1):2–10.PubMedCrossRef
10.
Loge JH, Ekeberg Ø, Kaasa S. Fatigue in the general norwegian population: Normative data and associations. J Psychosomatic Res. 1998;45(1):53–65.CrossRef
11.
Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–70.PubMedCrossRef
12.
White CM, van Doorn PA, Garssen MP, Stockley RC. Interventions for fatigue in peripheral neuropathy. Cochrane Database Syst. Rev. 2014(12):CD008146.
13.
Lerdal A, Wahl AK, Rustøen T, Hanestad BR, Moum T. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health. 2005;33(2):123–30.PubMedCrossRef
14.
Ricci JA, Chee E, Lorandeau AL, Berger J. Fatigue in the US workforce: prevalence and implications for lost productive work time. J Occup Environ Med. 2007;49(1):1–10.PubMedCrossRef
15.
Graham CD, Rose MR, Grunfeld EA, Kyle SD, Weinman J. A systematic review of quality of life in adults with muscle disease. J Neurol. 2011;258(9):1581–92.PubMedCrossRef
16.
Eddy L, Cruz M. The relationship between fatigue and quality of life in children with chronic health problems: a systematic review. J Spec Pediatr Nurs. 2007;12(2):105–14.PubMedCrossRef
17.
Maher C, Crettenden A, Evans K, Thiessen M, Toohey M, Watson A, et al. Fatigue is a major issue for children and adolescents with physical disabilities. Dev Med Child Neurol. 2015;57(8):742–7.PubMedCrossRef
18.
McCabe M. Fatigue in children with long-term conditions: an evolutionary concept analysis. J Adv Nurs. 2009;65(8):1735–45.PubMedCrossRef
19.
Luntamo T, Sourander A, Santalahti P, Aromaa M, Helenius H. Prevalence changes of pain, sleep problems and fatigue among 8-year-old children: years 1989, 1999, and 2005. J Pediatr Psychol. 2012;37(3):307–18.PubMedCrossRef
20.
Gold JI, Mahrer NE, Yee J, Palermo TM. Pain, fatigue, and health-related quality of life in children and adolescents with chronic pain. Clin J Pain. 2009;25(5):407–12.PubMedPubMedCentralCrossRef
21.
Penner I-K, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. 2017;13(11):662–75.PubMedCrossRef
22.
Menting J, Tack CJ, Bleijenberg G, Donders R, Droogleever Fortuyn HA, Fransen J, et al. Is fatigue a disease-specific or generic symptom in chronic medical conditions? Health Psychol. 2018;37(6):530–43.PubMedCrossRef
23.
Thomas S, Kersten P, Thomas PW, Slingsby V, Nock A, Jones R, et al. Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ). BMJ Open. 2015;5(10):e008274.
24.
Bryson B, Bogart K, Atwood M, Fraser K, Locke T, Pugh K, et al. Navigating the unknown: A content analysis of the unique challenges faced by adults with rare diseases. J Health Psychol. 2019:1359105319828150.
25.
Jaeger G, Röjvik A, Berglund B. Participation in society for people with a rare diagnosis. Disabil Health J. 2015;8(1):44–50.PubMedCrossRef
26.
Petersen A. The best experts: the narratives of those who have a genetic condition. Soc Sci Med. 2006;63(1):32–42.PubMedCrossRef
27.
JamesLindAlliance. Rare Inherited Anaemias Priority Setting Partnership. 2018.
28.
Shapiro S, Stephensen D, Camp C, Carroll L, Collins P, Elston D, et al. The top 10 research priorities in bleeding disorders: a James Lind Alliance Priority Setting Partnership. Br J Haematol. 2019;186(4):e98.
29.
Mickute G, Staley K, Delaney H, Gardiner O, Hunter A, Keen R, et al. Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance. Orphanet J Rare Dis. 2020;15(1):1–7.CrossRef
30.
JamesLindAlliance;. Mitochondrial disease PRIORITY SETTING PARTNERSHIP: setting research priorities with patients, carers and clinicians.: James Lind Alliance; 2020.
31.
Fineout-Overholt E, Johnston L. Teaching EBP: Asking searchable, answerable clinical questions. Worldviews Evid-Based Nurs. 2005;2(3):157–60.PubMedCrossRef
32.
Hjollund NH, Andersen JH, Bech P. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes. 2007;5:12.PubMedPubMedCentralCrossRef
33.
Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol rheumatoid arthritis fatigue multi-dimensional questionnaire (braf mdq), bristol rheumatoid arthritis fatigue numerical rating scales (braf nrs) for severity, effect, and coping, chalder fatigue questionnaire (cfq), checklist individual strength (cis20r and cis8r), fatigue severity scale (fss), functional assessment chronic illness therapy (fatigue)(facit-f), multi-dimensional assessment of fatigue (maf), multi-dimensional fatigue inventory (mfi), pediatric quality of life (pedsql) multi-dimensional fatigue scale, profile of fatigue (prof), short form 36 vitality subscale (sf-36 vt), and visual analog scales (vas). J Arthritis Care Res. 2011;63(S11):S263–86.CrossRef
34.
Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQOL). Arthritis Care Res. 2011;63(S11):S383–412.CrossRef
35.
Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32(5):811–9.PubMed
36.
Olson K. A new way of thinking about fatigue: a reconceptualization. Oncol Nurs Forum. 2007;34(1):93–9.PubMedCrossRef
37.
Morel T, Cano SJ. Measuring what matters to rare disease patients–reflections on the work by the IRDiRC taskforce on patient-centered outcome measures. Orphanet J Rare Dis. 2017;12(1):171.PubMedPubMedCentralCrossRef
38.
Pham MT, Rajić A, Greig JD, Sargeant JM, Papadopoulos A, McEwen SA. A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synthesis Methods. 2014;5(4):371–85.CrossRef
39.
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef
40.
Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6.PubMedCrossRef
41.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan: a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):1–10.CrossRef
42.
Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Library Assoc: JMLA. 2016;104(3):240.CrossRef
43.
Schwid SR, Tyler CM, Scheid EA, Weinstein A, Goodman AD, McDermott MP. Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler J. 2003;9(5):503–8.CrossRef
44.
Jarad NA, Sequeiros IM, Patel P, Bristow K, Sund Z. Fatigue in cystic fibrosis: a novel prospective study investigating subjective and objective factors associated with fatigue. Chron Respir Dis. 2012;9(4):241–9.PubMedCrossRef
45.
Johnston BC, Miller PA, Agarwal A, Mulla S, Khokhar R, De Oliveira K, et al. Limited responsiveness related to the minimal important difference of patient-reported outcomes in rare diseases. J Clin Epidemiol. 2016;79:10–21.PubMedCrossRef
46.
Salek MS, Ionova T, Johns JR, Oliva EN. Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency. Qual Life Res. 2019;28(2):399–410.PubMedCrossRef
47.
Symonds T, Randall JA, Campbell P. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients. Muscle Nerve. 2017;56(1):86–92.PubMedCrossRef
48.
Martí‐Carvajal AJ, An, V, Cardona AF, Solà I. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database of Systematic Reviews. 2014(10):CD010340.
49.
Schoser B, Bilder DA, Dimmock D, Gupta D, James ES, Prasad S. The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurol. 2017;17(1):202.PubMedPubMedCentralCrossRef
50.
Tarnopolsky M, Katzberg H, Petrof BJ, Sirrs S, Sarnat HB, Myers K, et al. Pompe disease: diagnosis and management. evidence-based guidelines from a Canadian expert panel. Can J Neurol Sci. 2016;43(4):472–85.
51.
Jamieson N, Fitzgerald D, Singh-Grewal D, Hanson CS, Craig JC, Tong A. Children’s experiences of cystic fibrosis: a systematic review of qualitative studies. Pediatrics. 2014;133(6):e1683–97.PubMedCrossRef
52.
Zion YC, Pappadopulos E, Wajnrajch M, berg DE, Rosenbaum H. Rethinking fatigue in Gaucher disease. Mol Genet Metab. 2016;111(1):S30–S1.
53.
Rath A, Salamon V, Peixoto S, Hivert V, Laville M, Segrestin B, et al. A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome? Trials. 2017;18(1):1–11.CrossRef
54.
Bathen T, Velvin G, Rand-Hendriksen S, Robinson HS. Fatigue in adults with Marfan syndrome, occurrence and associations to pain and other factors. Am J Med Genet A. 2014;164A(8):1931–9.PubMedCrossRef
55.
Johansen H, Bathen T, Andersen LO, Rand-Hendriksen S, Ostlie K. Chronic pain and fatigue in adults with congenital unilateral upper limb deficiency in Norway. A cross-sectional study. PloS one. 2018;13(1):e0190567.
56.
Laberge L, Gallais B, Auclair J, Dauvilliers Y, Mathieu J, Gagnon C. Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1. J Neurol. 2020;267(2):461–8.PubMedCrossRef
57.
Hagemans ML, van Schie SP, Janssens AC, van Doorn PA, Reuser AJ, van der Ploeg AT. Fatigue: an important feature of late-onset Pompe disease. J Neurol. 2007;254(7):941–5.PubMedPubMedCentralCrossRef
58.
Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A, Aromataris EJBmrm. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. 2018;18(1):143.
59.
Martí‐Carvajal AJ, Anand V, Cardona AF, Sola I. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database Syst Rev. 2014(10).
60.
Gruet M. Fatigue in chronic respiratory diseases: theoretical framework and implications for real-life performance and rehabilitation. Front Physiol. 2018;9:1285.PubMedPubMedCentralCrossRef
61.
Cramp F, Hewlett S, Almeida C, Kirwan JR, Choy EH, Chalder T, et al. Non‐pharmacological interventions for fatigue in rheumatoid arthritis. Cochrane Database of Syst Rev. 2013(8).
62.
Ho LY, Ng SS. Non-pharmacological interventions for fatigue in older adults: a systematic review and meta-analysis. Age Ageing. 2020;49(3):341–51.PubMedCrossRef
63.
Moss-Morris R, Harrison AM, Safari R, Norton S, van der Linden ML, Picariello F, et al. Which behavioural and exercise interventions targeting fatigue show the most promise in multiple sclerosis? A systematic review with narrative synthesis and meta-analysis. Behav Res Therapy. 2021;137:103464.
64.
Whittal A, Meregaglia M, Nicod E. The use of patient-reported outcome measures in rare diseases and implications for health technology assessment. Patient. 2021;14(5):485–503.PubMedPubMedCentralCrossRef
65.
Slade A, Isa F, Kyte D, Pankhurst T, Kerecuk L, Ferguson J, et al. Patient reported outcome measures in rare diseases: a narrative review. Orphanet J Rare Dis. 2018;13(1):61.PubMedPubMedCentralCrossRef
66.
Nijhuis W, Franken A, Ayers K, Damas C, Folkestad L, Forlino A, et al. A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta. Orphanet J Rare Dis. 2021;16(1):1–16.CrossRef
67.
Benjamin K, Vernon MK, Patrick DL, Perfetto E, Nestler-Parr S, Burke L. Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: an ISPOR COA emerging good practices task force report. Value in Health. 2017;20(7):838–55.PubMedCrossRef
68.
Whitehead LC, Unahi K, Burrell B, Crowe MT. The experience of fatigue across long-term conditions: a qualitative meta-synthesis. J Pain Symptom Manage. 2016;52(1):131–43.PubMedCrossRef
Metadata
Title
Experienced fatigue in people with rare disorders: a scoping review on characteristics of existing research
Authors
Trine Bathen
Heidi Johansen
Hilde Strømme
Gry Velvin
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Fatigue
Published in
Orphanet Journal of Rare Diseases / Issue 1/2022
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-021-02169-6

Other articles of this Issue 1/2022

Orphanet Journal of Rare Diseases 1/2022 Go to the issue

Research

Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases

Research

Poor education and urgent information need for emergency physicians about rare diseases in China

Correction

Correction: Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019

Position statement

Clinical management guidelines for Friedreich ataxia: best practice in rare diseases

Research

Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study

Research

Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency